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Abstract
Background: Primary and metastatic cancers that affect bone are frequently associated with severe and intractable
pain. The mechanisms underlying the development of bone cancer pain are largely unknown. The aim of this
study was to determine whether enhanced excitability of primary sensory neurons contributed to peripheral
sensitization and tumor-induced hyperalgesia during cancer condition. In this study, using techniques of whole-cell
patch-clamp recording associated with immunofluorescent staining, single-cell reverse-transcriptase PCR and
behavioral test, we investigated whether the intrinsic membrane properties and the excitability of small-sized
dorsal root ganglion (DRG) neurons altered in a rat model of bone cancer pain, and whether suppression of DRG
neurons activity inhibited the bone cancer-induced pain.
Results: Our present study showed that implantation of MRMT-1 tumor cells into the tibial canal in rats produced
significant mechanical and thermal hyperalgesia in the ipsilateral hind paw. Moreover, implantation of tumor cells
provoked spontaneous discharges and tonic excitatory discharges evoked by a depolarizing current pulse in small-
sized DRG neurons. In line with these findings, alterations in intrinsic membrane properties that reflect the
enhanced neuronal excitability were observed in small DRG neurons in bone cancer rats, of which including: 1)
depolarized resting membrane potential (RMP); 2) decreased input resistance (Rin); 3) a marked reduction in current
threshold (CT) and voltage threshold (TP) of action potential (AP); 4) a dramatic decrease in amplitude, overshot,
and duration of evoked action potentials as well as in amplitude and duration of afterhyperpolarization (AHP); and
5) a significant increase in the firing frequency of evoked action potentials. Here, the decreased AP threshold and
increased firing frequency of evoked action potentials implicate the occurrence of hyperexcitability in small-sized
DRG neurons in bone cancer rats. In addiotion, immunofluorescent staining and single-cell reverse-transcriptase
PCR revealed that in isolated small DRG neurons, most neurons were IB4-positive, or expressed TRPV1 or CGRP,
indicating that most recorded small DRG neurons were nociceptive neurons. Finally, using in vivo behavioral test,
we found that blockade of DRG neurons activity by TTX inhibited the tumor-evoked mechanical allodynia and
thermal hyperalgesia in bone cancer rats, implicating that the enhanced excitability of primary sensory neurons
underlied the development of bone cancer pain.
Conclusions: Our present results suggest that implantation of tumor cells into the tibial canal in rats induces an
enhanced excitability of small-sized DRG neurons that is probably as results of alterations in intrinsic electrogenic
properties of these neurons. Therefore, alterations in intrinsic membrane properties associated with the
hyperexcitability of primary sensory neurons likely contribute to the peripheral sensitization and tumor-induced
hyperalgesia under cancer condition.
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Bone cancer pain resulting from primary tumors or
tumors that metastasize to bone is one of the most
severe and intractable types of cancer pain, which
reduces the quality of the cancer patient’s life [1,2].
Bone cancer pain is generally consists of ongoing pain
and breakthrough or incident pain, which are character-
ized by pathological symptoms, such as spontaneous
pain, hyperalgesia, and allodynia [3,4]. Studies using
rodent models of bone cancer pain have revealed that
tumor growth in these models concurrently evokes
mechanical and thermal hyperalgesia [5-7], sensitization
of nociceptive dorsal horn neurons [6], sensitization of
primary afferent C nociceptors that innervate skin over-
lying the tumor [8-10], and development of injury to
primary afferent nerve fibers that innervate the tumor-
bearing bone, where the injury is accompanied by a
stereotypic set of cellular and neurochemical changes in
the dorsal root ganglia (DRG) [11]. It is now suggested
that sensitization of primary afferent C nociceptors
innervating tissue near the tumor likely contribute to
the chronic pain and hyperalgesia accompanying the
cancer condition [9,10]. However, alterations in the
intrinsic electrogenic properties and the excitability of
primary afferent DRG neurons in the condition of bone
cancer pain still remain largely unknown.
Electrophysiological recordings from primary sensory
neurons with transected peripheral axons indicate that
the somata in the DRG can become hyperexcitable
[12,13]. Damage to the peripheral nervous system,
which produces behavioural signs of neuropathic pain,
induces long-lasting hyperexcitability of sensory neurons
in diverse species [14,15]. In mammals, injury affecting
the axons or somata of sensory neurons having their
somata in DRGs often causes hyperexcitability that may
lead to spontaneous firing, neuropathic pain, and par-
esthesias [16,17]. Increases in excitability in all types of
DRG sensory neurons within weeks of axotomy have
been found, although electrophysiological changes
appear to vary among types of neurons and with the
type of injury [13,18]. In large and medium A-cells axot-
omy induced by sciatic nerve section or spinal nerve
ligation caused a reduction of excitation threshold, an
increase in duration and in rise time of the action
potential, whereas in small C-cells axotomy reduced
action potential threshold but did not significantly
change resting membrane potential, action potential
duration, or maximal depolarization rate [12,13,18-20].
In addition, nerve injury led to a significant reduction of
the rheobase, an index of neuronal excitability, in all
types of cells [18,19]. It has been suggested that the
nerve injury-induced increase in excitability is related to
the depolarizing shift of the resting membrane potential
(RMP) in C-cells and to the increase in apparent input
resistance near the RMP in A-cells [18].
Enhanced excitability of nociceptive DRG neurons
have also been observed in rodent models of inflamma-
tory pain [21-23]. Decreases in durations of action
potentials (C- and Aδ-fibre units) and afterhyperpolari-
sations (A-fibre units) occur in somata of nociceptive
DRG neurons during hindlimb inflammation induced in
young guinea-pigs by intradermal injections of complete
Freund’s adjuvant (CFA) into the ipsilateral leg and foot
[21]. Hindlimb inflammation also causes a significant
increase in conduction velocity of nociceptive primary
sensory neurons during inflammation, as well as a sig-
nificant decrease in the mean electrical threshold for eli-
citing the C and Aδ components of compound action
potentials of both dorsal root and sural nerves [24]. The
alterations in membrane properties of nociceptors likely
permit higher discharge frequencies, and thus contribut-
ing to inflammatory hyperalgesia [22,24,25]. Inflamma-
tory mediators, by increasing the excitability of DRG
somata via augmentation of Nav1.9 current [26] or sup-
pression of A-type K
+ current [23], may contribute to
nociceptors’ hyperexcitability during peripheral inflam-
mation, or even contribute to chronic compression of
the DRG (CCD)-induced neuronal hyperexcitability and
to hyperalgesia and tactile allodynia [27].
In the present study, using whole-cell patch-clamp
recording methods, we investigated whether the intrinsic
electrogenic properties and the excitability of small-sized
DRG neurons altered in a rat model of bone cancer
pain. The aim of this study was to determine whether
enhanced excitability of primary sensory neurons con-
tributed to peripheral sensitization and tumor-induced
hyperalgesia under cancer condition.
Results
Tumor-evoked mechanical allodynia and thermal
hyperalgesia
Consistent with previous reports [28,29], implantation of
MRMT-1 tumor cells into the tibial canal in rats pro-
duced significant mechanical allodynia (Figure 1A). The
50% paw withdrawal threshold (PWT) to von Frey fila-
ments in the tumor-bearing hind paw in MRMT-1 rats
decreased from 15.08 ± 0.01 g of the baseline level to
10.95 ± 0.93 g by day 10 after implantation (P <0 . 0 0 1 ) .
The further decrease in the 50% PWT was observed
from day 14 (5.66 ± 0.75 g) to day 21 (3.68 ± 0.65 g)
until the last testing session on day 28 (2.94 ± 0.35 g).
In contrast, the 50% PWT of the injected hind paw in
heat-killed (HK)- and PBS-implanted rats had no signifi-
cant alteration during the time course of post-inocula-
tion and were higher than those in MRMT-1 rats from
day 10 after implantation (P < 0.001, P < 0.001).
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thermal hyperalgesia (Figure 1B). Mean paw withdrawal
latency (PWL) to the radiant heat stimulation was 13.20
± 0.33 s prior to implantation of tumor cells. By day 10
after implantation, PWL began to decrease (11.26 ± 0.51
s, P < 0.05) in the tumor-bearing hind paw in MRMT-1
rats. The PWL decreased further to 7.85 ± 0.54 s by day
28 (P < 0.001). In contrast, the PWL of the injected
hind paw in heat-killed (HK)- and PBS-implanted rats
remained unchanged and were longer than those in
MRMT-1 rats from day 10 after implantation (P <
0.001, P < 0.001). Thus, implantation of MRMT-1
tumor cells into the tibial canal in rats produced signifi-
cant mechanical allodynia and thermal hyperalgesia,
indicating the development of tumor-induced bone can-
cer pain.
Tumor induced spontaneous discharges and tonic
excitation in isolated small-sized DRG neurons
To determine whether the excitability of primary sensory
neurons increased in bone cancer rats, we examined the
spontaneous activities and evoked discharges in small-
sized DRG neurons in naïve, PBS-, HK-, and MRMT-1-
rats. We found that implantation of MRMT-1 tumor
cells into the tibial canal in rats provoked spontaneous
discharges and tonic excitatory discharges evoked by 1-s,
300-pA depolarizing current pulse, recorded from small-
sized DRG neurons. As shown in Figure 2A, in PBS (0/
45)-, HK (0/49)-treated, or naïve (0/63) rats, no sponta-
neous activity was observed in all recorded small DRG
neurons, whereas in MRMT-1-implanted rats, 9 of 58
(15.52%) recorded DRG neurons exhibited spontaneous
discharges. Moreover, as compared with PBS (1/45,
2.22%)-, HK (1/49, 2.04%)-treated, or naïve (2/63, 3.17%)
rats, more neurons (25/58, 43.10%) generated tonic
excitatory discharges evoked by a depolarizing current
pulse (1 s, 300 pA) in bone cancer rats (Figure 2B). The
results suggested that enhanced excitability in small-sized
DRG neurons occurred in bone cancer rats.
Decreases in the depolarized current threshold (CT) and
the membrane input resistance (Rin) in small-sized DRG
neurons in MRMT-1-rats
To investigate whether the tumor-induced enhancement
of excitability in small-sized DRG neurons resulted from
the alteration of intrinsic electrogenic properties, we
measured the neuronal intrinsic membrane properties
such as resting membrane potential (RMP), membrane
input resistance (Rin), and various parameters of evoked
action potentials, which reflecting excitability (Table 1).
In this study, the recorded small DRG neurons were
initially divided into three types on the basis of the
depolarized current threshold (CT) for eliciting the 1
st
action potential: the low-firing threshold (LT) neurons
(CT < 50 pA), the medium-firing threshold (MT) neu-
rons (CT: 50 - 100 pA), and the high-firing threshold
(HT) neurons (CT > 100 pA). The results showed that
in contrast to control rats, the CT values decreased sig-
nificantly in low-, or medium-, but not high-firing
threshold neurons in bone cancer rats. For example, in
LT neurons, the CT value (in pA) decreased to 20.9 ±
1.5 in MRMT-1-rats from 29.8 ± 2.0, 28.9 ± 2.2, and
28.9 ± 2.4 in naïve, PBS-, and HK-treated rats, respec-
tively (p < 0.001, as compared with control groups, two-
tailed Student’s t-test). Similar results were observed in
MT neurons, whereas in HT neurons, no significant dif-
ference in the CT values was observed in MRMT-1-rats
as compared with the control rats (Table 1).
Similarly, the membrane input resistance (Rin)a l s o
decreased markedly in LT-, MT-, but not HT-neurons in
Figure 1 Changes in 50% paw withdrawal threshold (PWT) to von Frey filaments and paw withdrawal latency (PWL) to radiant heat in
rats with intra-tibial injections of MRMT-1 cells.( A): 50% PWT; (B): PWL. Note that implantation of MRMT-1 tumor cells into the tibial canal in
rats produced significant decreases in 50% PWT and PWL in contrast to PBS or heat-killed cells injection. *p < 0.05, **p < 0.01, ***p < 0.001, as
compared with PBS-implanted rats;
#p < 0.05,
##p < 0.01,
###p < 0.001, as compared with heat-killed (HK) cells-implanted rats, two-way ANOVA
followed by Bonferroni post-hoc test.
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neurons, the mean Rin (in MΩ) was 654.0 ± 20.1, 634.5 ±
28.5, and 638.1 ± 24.9 in naïve, PBS-, and HK-treated rats,
respectively; whereas it decreased dramatically to 546.3 ±
15.3 in MRMT-1-rats (p <0 . 0 0 1 ,a sc o m p a r e dw i t hc o n -
trol groups, two-tailed Student’s t-test). The mean Rin also
decreased significantly in MT neurons (p < 0.05), but no
significant decrease was observed in HT neurons in
MRMT-1-rats (p > 0.05) (Table 1).
Depolarization in resting membrane potential (RMP) and
reduction in action potential threshold (TP) in small-sized
DRG neurons in MRMT-1-rats
Implantation of MRMT-1 tumor cells into the tibial
canal in rats caused a more depolarized RMP and low-
ered AP threshold (TP) in LT-, MT-, but not HT-neu-
rons. Therefore, the difference decreased between RMP
a n dT P .A ss h o w ni nF i g u r e3 ,i nL Tn e u r o n s ,am o r e
depolarized RMP (in mV) in MRMT-1-rats (-45.6 ± 0.5)
was observed than that in naïve (-50.6 ± 0.5), PBS (-50.3
± 0.7)-, and HK (-50.5 ± 0.6)-treated rats (p < 0.001, as
compared with control groups, two-tailed Student’s t-
test). Similar depolarization of RMP was also observed
in MT (p < 0.01), but not in HT (p > 0.05) neurons in
MRMT-1-rats.
On the contrary, a significantly lowered TP (in mV)
was observed in MRMT-1-rats (-30.7 ± 0.6) as com-
pared with those in naïve (-27.6 ± 0.8), PBS (-27.8 ±
0.8)-, and HK (-26.6 ± 1.0)-treated rats in LT or MT
neurons (p < 0.01), but not in HT neurons (p > 0.05),
indicating a reduction of AP threshold in these neurons
in bone cancer rats. Additionally, the rise rate of TP
((RMP-TP)/duration from RMP to TP) also increased
obviously in LT (p < 0.05) but not in MT or HT neu-
rons (p > 0.05) in MRMT-1-rats (Table 1).
Decreases in amplitude, overshot, and duration of evoked
action potentials in small-sized DRG neurons in MRMT-1-
rats
As shown in Table 1, implantation of MRMT-1 tumor
cells into the tibial canal in rats significantly decreased
the parameters of evoked action potentials (AP) such as
amplitude (94.2 ± 1.9 mV vs. 102.6 ± 2.6 mV, p <0 . 0 1 ) ,
overshot (45.7 ± 1.9 mV vs. 54.7 ± 1.7 mV, p < 0.001),
and duration (34.3 ± 1.4 ms vs. 44.7 ± 3.1 ms, p <
0.001) in LT neurons (MRMT-1 group vs. HK group,
two-tailed Student’s t-test). Except for the decreased
overshot of AP in MT neurons (46.1 ± 2.9 mV vs. 56.0
±2 . 6m V ,p < 0.05), however, those parameters were
not significantly decreased in MT and HT neurons in
MRMT-1-rats.
Decreases in amplitude and duration of
afterhyperpolarization (AHP) of evoked action potentials
in small-sized DRG neurons in MRMT-1-rats
Apart from the decreased amplitude, overshot, and
duration of evoked action potentials, other parameters
such as amplitude and duration of the AHP also
decreased in LT neurons in MRMT-1-rats. As shown in
Table 1 and Figure 4, the AHP amplitude (in mV)
decreased dramatically in LT neurons in MRMT-1-rats
(14.7 ± 0.7) by contrast with that in naïve (19.2 ± 0.8),
PBS (18.9 ± 1.3)-, and HK (19.7 ± 1.3)-treated rats (p <
0.001, two-tailed Student’s t-test). The AHP amplitude
also decreased obviously in MT (p < 0.05)-, but not in
HT (p > 0.05)-neurons in bone cancer rats as compared
to control rats. Similarly, the AHP duration (in ms) at
80% repolarization (AHP80%) also shortened obviously
in LT neurons in MRMT-1-rats (14.6 ± 0.6) in contrast
to naïve (17.6 ± 1.1), PBS (17.7 ± 1.4)-, and HK (18.2 ±
1.7)-treated rats (p < 0.05, two-tailed Student’s t-test).
Figure 2 Spontaneous discharges and evoked tonic discharges in small-sized DRG neurons in MRMT-1-rats.( A): Representative of
spontaneous discharges. (B): Representative of evoked discharges. The red trace represents the discharges recorded from representative small
DRG neurons in MRMT-1-implanted rats. Note that implantation of MRMT-1 tumor cells into the tibial canal in rats provoked spontaneous
discharges and evoked tonic discharges in MRMT-1-rats but not control rats.
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RMP Rin CT TP TP rise rate AP
amplitude
AP overshot AP duration AHP
amplitude
AHP80%
duration
AP frequency
mV MΩ pA mV v/s mV mV ms mV ms Spikes/s
CT
<5 0
pA
Naïve -50.6 ± 0.5 (29) 654.0 ± 20.1 (33) 29.8 ± 2.0 (29) -27.6 ± 0.8
(38)
0.8 ± 0.1
(30)
101.8 ± 1.9
(34)
55.9 ± 1.4 (34) 44.6 ± 2.9 (30) 19.2 ± 0.8 (40) 17.6 ± 1.1 (35) 20.5 ± 1.8 (30)
PBS -50.3 ± 0.7 (18) 634.5 ± 28.5 (13) 28.9 ± 2.2 (18) -27.8 ± 0.8
(29)
0.7 ± 0.1
(24)
103.4 ± 1.8
(24)
55.5 ± 1.6 (24) 43.2 ± 2.6 (23) 18.9 ± 1.3 (25) 17.7 ± 1.4 (21) 20.6 ± 2.3 (14)
MRMT-
1
-45.6 ± 0.5 (52)
***
546.3 ± 15.3 (60)
***
20.9 ± 1.5 (44)
***
-30.7 ± 0.6
(55) **
0.9 ± 0.1
(45) *
94.2 ± 1.9
(55) **
45.7 ± 1.9 (47)
***
34.3 ± 1.4 (54)
***
14.7 ± 0.7 (51)
***
14.6 ± 0.6 (49)
*
31.4 ± 1.9 (32)
***
HK -50.5 ± 0.6 (13) 638.1 ± 24.9 (19) 28.9 ± 2.4 (13) -26.6 ± 1.0
(23)
0.7 ± 0.1
(13)
102.6 ± 2.6
(16)
54.7 ± 1.7 (16) 44.7 ± 3.1 (16) 19.7 ± 1.3 (11) 18.2 ± 1.7 (13) 20.3 ± 2.6 (12)
Naïve -51.7 ± 1.1 (12) 593.0 ± 22.3 (14) 85.0 ± 3.3 (13) -20.1 ± 0.7
(19)
1.9 ± 0.2
(11)
104.7 ± 3.4
(17)
55.1 ± 1.9 (17) 24.5 ± 2.1 (15) 19.7 ± 1.5 (16) 10.6 ± 1.4 (16) 10.5 ± 1.7 (15)
CT50 ~100
pA
PBS -51.1 ± 0.6 (7) 594.6 ± 25.4 (6) 86.4 ± 4.0 (7) -19.9 ± 1.5 (6) 2.0 ± 0.3 (5) 105.1 ± 4.3
(6)
56.5 ± 3.1 (6) 24.0 ± 1.9 (6) 20.2 ± 2.6 (7) 11.2 ± 1.7 (7) 13.8 ± 2.2 (6)
HK -52.6 ± 1.5 (11) 596.9 ± 26.4 (7) 85.5 ± 2.7 (11) -20.0 ± 1.1
(10)
2.0 ± 0.2
(10)
104.0 ± 2.4
(10)
56.0 ± 2.6 (9) 24.0 ± 1.7 (8) 19.7 ± 2.1 (8) 10.7 ± 1.5 (9) 12.2 ± 3.4 (9)
MRMT-
1
-48.6 ± 0.5 (16)
**
486.5 ± 25.8 (17)
**
72.2 ± 4.0 (16)
*
-23.4 ± 1.0
(17) **
2.3 ± 0.2
(14)
98.7 ± 2.6
(17)
46.1 ± 2.9 (15)
*
22.1 ± 1.2 (17) 14.4 ± 1.3 (17)
*
11.4 ± 1.0 (17) 19.3 ± 3.2 (12)
*
CT
> 100
pA
Naïve -54.6 ± 2.1 (7) 550.5 ± 40.8 (9) 157.9 ± 12.6
(7)
-16.6 ± 1.0 (8) 5.4 ± 1.1 (5) 103.7 ± 3.6
(7)
54.1 ± 3.3 (5) 17.5 ± 3.2 (6) 10.8 ± 1.3 (8) 6.3 ± 0.6 (6) 7.1 ± 3.4 (8)
PBS -54.1 ± 1.9 (7) 556.6 ± 35.3 (7) 158.6 ± 14.6
(7)
-18.8 ± 0.8 (9) 5.1 ± 0.7 (5) 107.9 ± 4.8
(7)
56.7 ± 3.7 (6) 15.1 ± 1.1 (6) 10.9 ± 1.8 (6) 6.1 ± 0.5 (5) 6.8 ± 2.9 (8)
HK -54.2 ± 1.6 (6) 552.0 ± 28.5 (6) 163.3 ± 13.2
(6)
-17.0 ± 1.2 (7) 5.1 ± 1.2 (5) 106.9 ± 6.3
(7)
56.2 ± 2.4 (6) 17.0 ± 4.6 (6) 10.6 ± 1.8 (6) 6.3 ± 0.6 (6) 7.3 ± 2.6 (6)
MRMT-
1
-51.2 ± 0.9 (13) 508.1 ± 24.9 (12) 161.7 ± 16.6
(9)
-20.2 ± 1.4 (9) 5.0 ± 0.9 (7) 103.3 ± 4.9
(10)
54.9 ± 2.6 (8) 13.9 ± 1.4 (9) 9.0 ± 1.39 (10) 6.3 ± 0.9 (7) 10.0 ± 4.3 (8)
Values are presented as mean ± S.E.M with the number given in parentheses. *p < 0.05, **p < 0.01,***p < 0.001, as compared with HK groups, two-tailed Student’s t-test. RMP: resting membrane potential; Rin: membrane
input resistance; CT: the depolarized current threshold for evoking the 1
st action potential; TP: threshold potential; AHP: afterhyperpolarization; AHP80% duration: AHP duration at 80% repolarization (AHP80%);
AP: action potential. Note that implantation of MRMT-1 tumor cells into the tibial canal in rats increased the cells excitability in low (CT < 50 pA)-, medium (CT: 50 - 100 pA)-, but not high (CT > 100 pA)-firing threshold
DRG neurons as assessed by the intrinsic electrogenic parameters.
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neurons in bone cancer rats.
Increase in firing frequency of evoked action potentials in
small-sized DRG neurons in MRMT-1-rats
Implantation of MRMT-1 tumor cells into the tibial
canal in rats increased the firing frequency of small-
sized DRG neurons evoked by a constant (1 s, 300 pA)
depolarizing current pulse. As shown in Table 1 and
Figure 5, the firing frequency of evoked action potentials
(in spikes/s) increased markedly in LT neurons in
MRMT-1-rats (31.4 ± 1.9) in contrast to naïve (20.5 ±
1.8), PBS (20.6 ± 2.3)-, and HK (20.3 ± 2.6)-treated rats
(p < 0.001, two-tailed Student’s t-test). The firing fre-
quency also increased obviously in MT (p <0 . 0 5 ) - ,b u t
not in HT (p > 0.05)-neurons in bone cancer rats as
compared to control rats.
No significant changes in excitability and intrinsic
membrane properties of small-sized DRG neurons in
MRMT-1-rats without allodynia
To clarify whether the alterations in intrinsic membrane
properties and the enhanced excitability of small-sized
DRG neurons were associated with behavioral changes
in bone cancer rats, we also examined the aforemen-
tioned properties in MRMT-1-rats without allodynia. As
Figure 3 Changes in resting membrane potentials (RMP) and action potential threshold (TP) of small-sized DRG neurons in rats with intra-
tibial injections of MRMT-1 cells. (A) - (C): Summary of the absolute values of RMP in low-, medium-, and high-firing threshold neurons in naïve,
PBS-, HK-, and MRMT-1-rats. (D)-( F): Summary of the absolute values of TP in naïve, PBS-, HK-, and MRMT-1-rats. *p <0 . 0 5 ,* * p < 0.01,***p < 0.001, as
compared with HK groups, two-tailed Student’s t-test. LT, MT, and HT mean low-, medium-, and high-firing threshold neurons, respectively. (G):
Representative of action potentials evoked by 100-ms, 25-pA depolarizing current pulse, recorded from low-firing threshold DRG neurons. The red
trace represents the discharges recorded from a representative small DRG neuron in a MRMT-1-implanted rat. Note that implantation of MRMT-1
tumor cells into the tibial canal in rats caused a depolarizing shift of RMP and a reduction of TP in small-sized DRG neurons.
Zheng et al. Molecular Pain 2012, 8:24
http://www.molecularpain.com/content/8/1/24
Page 6 of 18our expectation, no significant changes in excitability
and intrinsic membrane properties were observed in
small-sized DRG neurons in MRMT-1-rats without allo-
dynia (Additional file 1: Figure S1 and Additional file 3:
Table S1).
Characterization of the isolated small DRG neurons in rats
To further characterize the small-sized DRG neurons that
were examined in our present study, we first did
immunofluorescent staining of IB4, CGRP and TRPV1 in
isolated DRG neurons, respectively. The results showed
that in isolated small DRG neurons obtained from 5 rats
for each staining, the IB4-positive neurons were 71.9%
(340/473), the TRPV1-positive neurons were 66.1% (257/
389), and the CGRP-positive neurons were 27.7% (135/
487), indicating that most small-sized DRG neurons
recorded in our study were nociceptive neurons (Figure 6).
We then did single-cell reverse-transcriptase PCR to detect
Figure 4 Changes in the amplitude and duration of afterhyperpolarization (AHP) of action potentials recorded from small-sized DRG
neurons in rats with intra-tibial injections of MRMT-1 cells.( A)-( C): Summary of the AHP amplitude of action potentials in LT, MT, and HT
neurons in naïve, PBS-, HK-, and MRMT-1-rats. (D)-( F): Summary of the AHP duration at 80% repolarization (AHP80%) in naïve, PBS-, HK-, and
MRMT-1-rats. *p < 0.05,***p < 0.001, as compared with HK groups, two-tailed Student’s t-test. LT, MT, and HT mean low-, medium-, and high-
firing threshold neurons, respectively. (G): Representative of the AHP amplitude and duration of action potentials evoked by 100-ms, 40-pA
depolarizing current pulse, recorded from low-firing threshold DRG neurons. The red trace represents the discharges recorded from a
representative small DRG neuron in a MRMT-1-implanted rat. The vertical dot line to trough shows the AHP amplitude, and the horizontal dot
line shows the AHP80%. Action potentials have been amputated due to high gain. Note that implantation of MRMT-1 tumor cells into the tibial
canal in rats decreased the amplitude and duration of afterhyperpolarization (AHP) in small-sized DRG neurons.
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small DRG neuron after current-clamp recording. As
shown in Figure 7 and Additional file 4: Table S2 (supple-
mentary data), in 56 recorded small DRG neurons, 75.0%
(42/56) were TRPV1
+ neurons, 39.3% (22/56) were CGRP
+
neurons, whereas only 12.5% (7/56) were TRPV1
-/CGRP
-
neurons; among those, 35 were low (LT)-firing threshold
(CT < 50 pA) neurons (62.5%), 11 were medium (MT)-fir-
ing threshold (CT 50 ~ 100 pA) neurons (19.6%), and 10
were high (HT)-firing threshold (CT > 50 pA) neurons
(17.9%). In the 35 LT neurons, TRPV1
+/CGRP
+ neurons
were 34.3%, TRPV1
+/CGRP
- neurons were 45.7%,
TRPV1
-/CGRP
+ neurons were 11.4%, TRPV1
-/CGRP
-neu-
rons were 8.6%; In the 11 MT neurons, TRPV1
+/CGRP
+
neurons were 18.2%, TRPV1
+/CGRP
- neurons were 54.5%,
TRPV1
-/CGRP
+ neurons were 9.1%, while TRPV1
-/CGRP
-
neurons were 18.2%; Whereas, in the 10 HT neurons,
TRPV1
+/CGRP
+ neurons were 10%, TRPV1
+/CGRP
- neu-
rons were 50%, TRPV1
-/CGRP
+ neurons were 20%, while
TRPV1
-/CGRP
- neurons were increased to 20%, indicating
that TRPV1, CGRP or both were expressed in most LT
and MT neurons, whereas the cells that expressed TRPV1
or CGRP decreased significantly in HT neurons. Actually,
these results also revealed that the current threshold (CT)
Figure 5 Changes in the firing frequency of evoked action potentials recorded from small-sized DRG neurons in rats with intra-tibial
injections of MRMT-1 cells.( A)-( C): Summary of the action potential numbers (spikes/s) evoked by a 1-s, 300-pA depolarizing current pulse in
LT, MT, and HT neurons in naïve, PBS-, HK-, and MRMT-1-rats. *P < 0.05, ***P < 0.001, as compared with HK groups, two-tailed Student’s t-test.
(D): Representative of evoked action potentials recorded from LT (a), MT (b), and HT (c) neurons. LT, MT, and HT mean low-, medium-, and high-
firing threshold neurons, respectively. Note that implantation of MRMT-1 tumor cells into the tibial canal in rats increased the firing frequency of
evoked action potentials in LT and MT, but not HT neurons.
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expression in each small DRG neuron, e.g., the less TRPV1
mRNA expression, the higher CT in a DRG neuron.
Intrathecal administration of tetrodotoxin (TTX) inhibited
the tumor-evoked mechanical allodynia and thermal
hyperalgesia in bone cancer rats
Finally, we investigated whether intrathecal (i.t.) admin-
istration of tetrodotoxin (TTX), which was considered
to be able to block the neurons excitation, could inhibit
the tumor-evoked mechanical allodynia and thermal
hyperalgesia in bone cancer rats. Indeed, our results
demonstrated that i.t. injection of TTX (10 μg/kg, once
a day) significantly inhibited the tumor-evoked mechani-
cal allodynia (as assessed by 50% PWT) and thermal
hyperalgesia (as assessed by PWL) in MRMT-1-rats. As
shown in Figure 8A and 8B, both of the tumor-induced
decreases in 50% paw withdrawal threshold (PWT) to
von Frey filaments (9.96 ± 1.2 g versus 5.09 ± 1.3 g,
TTX versus NS, P < 0.01) and in paw withdrawal
latency (PWL) to radiant heat (12.82 ± 0.7 s versus 8.75
± 0.8 s, TTX versus NS, P < 0.001) were dramatically
inhibited in TTX-treated rats as compared with those in
saline-treated rats. To further clarify whether i.t. injec-
tion of TTX at our experimental dose affected the ani-
mal’s motor function, we performed inclined-plate test
to measure rats’ motor function before and after TTX
injection, respectively. The results showed that i.t. injec-
tion of TTX had no obvious motor dysfunction in con-
trast to vehicle injection (p >0 . 0 5 ,t w o - w a yA N O V A
followed by Bonferroni post-hoc test, Figure 8C). These
results suggested that suppression of DRG neurons
excitability likely inhibited the tumor-evoked mechanical
allodynia and thermal hyperalgesia in bone cancer rats.
Discussion
Tumor-evoked hyperalgesia and sensitization of small-
sized DRG neurons
Consistent with previous reports [28,29], we presently
observed that implantation of MRMT-1 tumor cells into
Figure 6 Immunofluorescent staining of IB4, CGRP and TRPV1 in isolated DRG neurons.( A1)-( A3): IB4-FITC staining to living cells. (B1)-
(C3): immunofluorescent staining of TRPV1 (B1 - B3) and CGRP (C1 - C3) in isolated DRG neurons. (A1)-( C1): viewed under bright field
microscope. (A2)-( C2): viewed under fluorescence microscope. (A3)-( C3): merged. Scale bar: 100 μm.
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and thermal hyperalgesia in the ipsilateral hind paw,
indicating the development of tumor-induced bone can-
cer pain. In addition, we also found that implantation of
tumor cells provoked spontaneous discharges and tonic
excitatory discharges evoked by 1-s, 300-pA depolarizing
current pulse in small-sized DRG neurons, suggesting a
sensitization or hyperexcitability of primary sensory neu-
rons appear to occurrence in cancer condition. Our pre-
sent results are consistent with previous reports that the
C-fiber nociceptors in mice with tumor-evoked hyperal-
gesia exhibited ongoing activity and sensitization to heat
stimuli [8]. These findings provided strong evidence to
the notion that sensitization of primary afferent DRG
neurons innervating tissue near the tumor likely contri-
bute to the persistent pain and hyperalgesia under can-
cer condition [8-10].
It has been suggested that neuronal sensitization refers
to an increase in excitability characterized by sponta-
neous activity, lowered response thresholds, and
increased response to suprathreshold stimuli [8], all of
which were observed in the present study. The most
striking difference in the responses of small-sized DRG
neurons in tumor-bearing rats was the high incidence of
spontaneous discharges and tonic excitatory discharges
evoked by a depolarizing current pulse. The depolarizing
current-induced tonic responses of small-sized DRG
neurons in bone cancer rats (Figure 2B) suggest the
appearance of neuronal hyperexcitability, while the
spontaneous activity is probably involved in the develop-
ment of spontaneous (ongoing) pain behaviors exhibited
in murine models of bone cancer pain [7,9]. Apart from
the tumor-evoked sensitization of C nociceptors [8],
sensitization of wide dynamic range (WDR), but not
high threshold (HT), nociceptive dorsal horn neurons to
mechanical, heat, and cold stimuli has also been
observed in mice with tumor-evoked hyperalgesia [6].
Ongoing activity in unmyelinated and myelinated noci-
ceptors has also been associated with nerve injury
[30,31] or tissue inflammation [32-34]. Clinical and
experimental observations implicate spontaneous activity
as a probable substrate of persistent neuropathic pain
and progressive degenerative neuropathies [35,36].
Taken together, our present study strongly suggests that
sensitization of primary sensory neurons contributes to
the tumor-induced hyperalgesia and ongoing pain.
Tumor-evoked hyperexcitability of small-sized DRG
neurons associated with alterations in the intrinsic
membrane properties
It has been demonstrated that following nerve injury
there is an enhancement of excitability in C cells of
DRG as evidenced by a reduction in AP threshold [13].
Specifically, the nerve injury-induced increase in excit-
ability, including depolarization of RMP, decreased AHP
and rheobase, and repetitive firing during depolarization,
is pronounced after direct injury by axotomy of L5 neu-
rons but is absent in adjacent L4 neurons after spinal
nerve ligation [37]. In guineapig DRG neurones,
decreased somatic AP and AHP durations are seen in
nociceptive but not low threshold mechanoreceptive
(LTM) neurones 2 or 4 days after complete Freund’s
adjuvant (CFA) treatment, suggesting that the altera-
tions in membrane properties of nociceptors may permit
higher discharge frequencies, thus contributing to
inflammatory hyperalgesia [21]. In line with these
Figure 7 Single-cell reverse- transcriptase PCR analysis for
TRPV1 and CGRP mRNA expression in each recorded LT, MT,
and HT DRG neuron.( A): Reverse transcription-PCR analysis of RNA
isolated from single DRG neuron using primer pairs for TRPV1,
CGRP, and actin. Negative control was processed without the
addition of primer pairs, while the DRG tissue was used as positive
control. (B): Summary of TRPV1 and CGRP mRNA expression in total
recorded LT (CT < 50 pA), MT (CT 50 ~ 100 pA), and HT (CT > 50
pA) DRG neurons.
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of intrinsic membrane properties in small-sized DRG
neurons in bone cancer rats, of which including: 1)
depolarized resting membrane potential (RMP); 2)
decreased input resistance (Rin); 3) a marked reduction
in AP current threshold (CT) and AP voltage threshold
(TP); 4) a dramatic decrease in amplitude, overshot, and
duration of evoked action potentials as well as in ampli-
tude and duration of AHP; and 5) a significant increase
in the firing frequency of evoked action potentials. In
this study, we only examined the small-sized DRG neu-
rons, most of which are considered as nociceptive pri-
mary sensory neurons. Indeed, the immunostaining
results showed that in acute isolated small DRG neu-
rons, most neurons were IB4-positive (71.9%), or
expressed TRPV1 (66.1%) or CGRP (27.7%). Addition-
ally, the single-cell reverse-transcriptase PCR also
demonstrated that in all recorded small DRG neurons,
75.0% were TRPV1
+ neurons, 39.3% were CGRP
+ neu-
rons, whereas only 12.5% were TRPV1
-/CGRP
- neurons.
These results suggest that most small-sized DRG neu-
rons recorded in our experiments are nociceptive
neurons.
Somata of the small-sized DRG neurons were classified
by their diameters (≤ 26 μm) and Cm (≤ 45 pF) as
described in previous reports [38,39]. In the present
study, we observed three types of small DRG neurons i.e.
low (LT)-, medium (MT)-, and high-firing threshold
( H T ) - D R Gn e u r o n sa sc l a s s i f i e db yt h eA Pc u r r e n t
threshold (CT), and all of the alterations in intrinsic
membrane properties appeared to occurrence in small-
sized DRG neurons of LT, or MT, but not HT cells in
bone cancer rats. In addition, by the single-cell reverse-
transcriptase PCR analysis, we also found that the current
threshold (CT) of action potential is likely related to
TRPV1 mRNA expression in each small DRG neuron, e.
g., the less TRPV1 mRNA expression, the higher CT in a
DRG neuron (Figure 7 and Additional file 4: Table S2).
Therefore, the classification of small-sized DRG neurons
by the current threshold of action potentials is probably
able to reflect their functional characters. For instance,
the lower CT of a small DRG neuron suggests a higher
TRPV1 mRNA expression, and more likely represents as
a nociceptive neuron. Although the mechanisms underly-
ing the development of bone cancer pain are largely
unclear, the decreased CT and increased firing frequency
of evoked action potentials implicated that the hyperex-
citability of small-sized DRG neurons likely contributed
to the tumor-induced hyperalgesia [2,40]. We speculate
that the depolarized RMP and the reduced TP may
account for the decreased CT in small -sized DRG neu-
rons as observed in tumor-bearing rats. Our observation
of a reduction in AP threshold in small-sized DRG neu-
rons is consistent with previous reports that nerve injury
results in an enhancement of excitability in C cells asso-
ciated with a reduction in AP threshold, and that one
possible explanation for this reduction is a preferential
increase in expression of TTX-sensitive sodium currents
[13,41]. For most of the membrane properties recorded
from small DRG neurons with our preparation, the
decreased input resistance (Rin) in bone cancer rats is
consistent with that of a decreased Rin in C-type neurons
in mouse DRG after partial colonic obstruction [42], but
inconsistent with that of increase in A cells, or no altera-
tion in C cells of axotomized rat DRGs [13,18]. The wide
range of changes in Rin suggests the possibility of differ-
ent underlying mechanisms. For example, Rin could be
decreased by a depolarization of the RMP and an increase
in Ih currents [43] or increased by the inhibition of K
+
currents [44], or unaffected by an enhancement of Na
+
currents [13,45,46] or reduction of Ca
2+ currents [47].
Therefore, the depolarization of the RMP is likely to
underlie the decreased Rin in small-sized DRG neurons in
MRMT-1 rats.
Figure 8 Effects of intrathecal (i.t.) injection of tetrodotoxin (TTX) on pain behaviors and motor function in rats with intra-tibial
injections of MRMT-1 cells.( A): 50% paw withdrawal threshold (PWT); (B): paw withdrawal latency (PWL); (C): inclined-plate test. Note that i.t.
injection of TTX inhibited the tumor-evoked (as assessed by 50% PWT) and thermal hyperalgesia (as assessed by PWL), but did not affect the
motor function in bone cancer rats. **p < 0.01, ***p < 0.001, as compared with i.t. injection of saline rats, two-way ANOVA followed by
Bonferroni post-hoc test.
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neurons in bone cancer rats also include a dramatic
decrease in amplitude, overshot, and duration of evoked
action potentials as well as in amplitude and duration of
AHP. These results are supported by the findings that
shorter duration of APs in C and Aδ-fibre nociceptive
neurons with decreased rise times in C-fibre nocicep-
tors, decreased fall times in C and Aδ-fibre units, and
shorter duration of AHP80% in Aδ- and Aa/b-fibre units
take place in nociceptive DRG neurons during CFA-
induced peripheral inflammation [21]. It has been
accepted that the changes in membrane properties
include alterations in level or activity of proteins
involved in pathways regulating cation channels, e.g.
channel subunit, cAMP-dependent protein kinases, pro-
tein kinase C or G proteins [48,49]. Together with pre-
vious findings that the AP rise time is faster in C-fibre
nociceptors after CFA-induced inflammation [21] and
the voltage-gated sodium channels are kinetically the
fastest channel type contributing to the AP, we infer
that an overall increase in sodium channel density, or
relative alterations in levels of sodium channels with dif-
fering kinetics [50] or modulation of pre- existing
sodium channels [26] likely contribute to the reduced
AP duration under cancer condition. Alternatively, the
decreased AP amplitude and overshot under cancer con-
dition are proposed due to the depolarization in RMP,
which reduced the driving force of voltage-gated sodium
currents [26,27].
Several studies have revealed that the rate of decay (i.
e. duration) of the AHP is depended on Ca
2+ influx that
affects the activation Ca
2+-dependent K
+ channels (K
Ca) [51-53]. Reduction of AP broading (i.e. duration)
during a train of APs would result in a reduced Ca
2+
influx and less activation of the Ca
2+-dependent K
+
channels, and therefore lead to a reduced AHP. Interest-
ingly, Kvb1.1-deficient mice, which show reduced AP
broading, also have a reduced AHP [54], whereas dia-
betic rats, which show increased AP broading, have an
increased AHP [55]. Thus the reduced AP duration in
small-sized DRG neurons provides an alternative expla-
nation for the reduced AHP under cancer condition.
Since AHP limits firing frequency, a reduction in the
AHP would be expected to increase the number of APs
in response to stimuli [53,56]. We therefore suggest that
the attenuation in AHP may reduce the inhibition on
firing, and thus lead to the enhancement in intrinsic
excitability under cancer condition [57]. Taken together,
the decrease in amplitude, overshot, and duration of
evoked action potentials as well as in amplitude and
duration of AHP likely contribute to the increased firing
frequency of evoked action potentials in small DRG
neurons in MRMT-1 rats.
Blockade of DRG neurons activity by TTX inhibited the
tumor-evoked mechanical allodynia and thermal
hyperalgesia in bone cancer rats
To further clarify whether enhanced excitability of pri-
mary sensory neurons contributes to the development of
peripheral sensitization and bone cancer pain, we exam-
ined the effects of tetrodotoxin (TTX) on the tumor-
evoked mechanical allodynia and thermal hyperalgesia
in bone cancer rats. We found that i.t. injection of TTX
significantly inhibited the tumor-evoked mechanical
allodynia (as assessed by 50% PWT) and thermal hyper-
algesia (as assessed by PWL) in MRMT-1-rats. Pre-
viously, using extracellular microelectrode recordings
from DRG that reflect the activity of single DRG neu-
ron, Omana-Zapata et al. [58] have reported that sys-
temic administration of TTX produces a dose-
dependent reduction in DRG neurons activity. A signifi-
cant decrease in DRG neurons activity is obtained at the
dose of 1 μg/kg, with complete inhibition usually
achieved at 10 μg/kg, and the ED50 value for TTX in
the DRG is 4.3 μg/kg. Based on these observations, we
t h e r e f o r ea p p l i e dT T Xa tt h ed o s eo f1 0μg/kg, which
was considered to be able to completely block the DRG
neurons activity, but can not significantly inhibit the
dorsal horn neurons activity, because the inhibitory
effect of TTX on DRG neurons activity is markedly
g r e a t e rt h a nt h a to nd o r s a lh o r nn e u r o n sa c t i v i t y ,e . g .
the ED50 value for TTX in the dorsal horn is 36.2 μg/kg
[58]. Indeed, we also found that i.t. injection of TTX at
10 μg/kg almost completely inhibited the DRG neurons
activity with little effect on the dorsal horn neurons
activity (data not shown). Our present results are consis-
tent with previous reports that a blockade of DRG neu-
rons activity with local application of lidocaine to the
DRG alleviated the mechanical hyperalgesia and tactile
allodynia in rat modesl of neuropathic pain [59-61].
Finally, to further elucidate whether the inhibitory
effects of TTX on tumor-evoked mechanical allodynia
and thermal hyperalgesia resulted from the TTX-
induced motor dysfunction, we performed inclined-plate
test to measure rats’ motor function before and after
TTX injection, respectively. Our results showed that i.t.
injection of TTX at our experimental dosage had no
obvious motor dysfunction in contrast to vehicle injec-
tion, indicating that the inhibitory effects of TTX on
tumor-evoked mechanical allodynia and thermal hyper-
algesia likely resulted from the TTX-induced inhibition
on DRG neurons activity. Taken together, these results
provide in vivo evidence to the notion that the enhanced
excitability of primary sensory neurons under cancer
condition likely contributes to the development of per-
ipheral sensitization and bone cancer pain, although we
can not conclude that cancer is unique in the
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as compared to other injuries.
Conclusions
In summary, our present study showed that: (1) implan-
tation of MRMT-1 tumor cells into the tibial canal in
rats produced significant mechanical and thermal hyper-
algesia in the ipsilateral hind paw; (2) implantation of
tumor cells induced an enhanced excitability of small-
sized DRG neurons that is probably as results of altera-
tions in intrinsic membrane properties of these neurons;
(3) Immunofluorescent staining and single-cell reverse-
transcriptase PCR revealed that in isolated small DRG
neurons, most neurons were IB4-positive, or expressed
TRPV1 or CGRP, indicating that most recorded small
DRG neurons were nociceptive neurons; (4) blockade of
DRG neurons activity by TTX inhibited the tumor-
evoked mechanical allodynia and thermal hyperalgesia
in bone cancer rats, implicating that the enhanced excit-
ability of primary sensory neurons underlied the devel-
opment of bone cancer pain. Thus, this study suggests
that alterations in intrinsic membrane properties asso-
ciated with the hyperexcitability of primary sensory neu-
rons likely contribute to the peripheral sensitization and
tumor-induced hyperalgesia under cancer condition.
Methods
Animals
Female Sprague-Dawley rats weighing 150 - 180 g at the
beginning of the experiment were used (Department of
Experimental Animal Sciences, Peking University Health
Science Center). The rats were housed in separated
cages with free access to food and water. The room
temperature was kept at 24 ± 1°C under natural light-
dark cycle. All animal procedures were carried out in
accordance with the guidelines of the International
Association for the Study of pain [62] and were
approved by the Animal Care and Use Committee of
Peking University.
Bone cancer pain model
Implantation of tumor cells
A rat model of bone cancer pain was established by
intra-tibial injections of syngeneic MRMT-1 rat mam-
mary gland carcinoma cells as previously described [28].
Briefly, after anesthetized with chloral hydrate (0.3 g/kg,
i.p.), the rat left tibia was carefully exposed, and a 23-
g a u g en e e d l ew a si n s e r t e di n t ot h ei n t r a m e d u l l a r yc a n a l
of the bone. It was then removed and replaced with a
long thin blunt needle attached to a 10-μl Hamilton syr-
inge containing the medium to be injected. A volume of
4 μl MRMT-1 rat mammary gland carcinoma cells (4 ×
10
4), inactivated (heat-killed) carcinoma cells or vehicle
(phosphorylated buffer solution, PBS) was injected into
the tibial bone cavity. Following injection the site was
sealed with bone wax, and the wound was finally closed.
None of the animals showed signs of motor dysfunction
after implantation of tumor cells.
Assessment of mechanical allodynia
Mechanical allodynia, as a behavioral sign of bone can-
cer pain, was assessed by measuring 50% paw withdra-
wal threshold (PWT) as described in our previous
reports [63,64]. The 50% PWT in response to a series of
von Frey filaments (Stoelting, Wood Dale, IL, USA) was
determined by the Up and Down method [65]. The rat
was placed on a metal mesh floor covered with an
inverted clear plastic cage (18 × 8 × 8 cm) and allowed
a 20-min period for habituation. Eight von Frey fila-
ments with approximately equal logarithmic incremental
(0.224) bending forces were chosen (0.41, 0.70, 1.20,
2.00, 3.63, 5.50, 8.50, and 15.10 g). Each trial started
with a von Frey force of 2.00 g delivered perpendicularly
to the plantar surface of the left hindpaw for about 2 - 3
s. An abrupt withdrawal of the foot during stimulation
or immediately after the removal of the hair was
recorded as a positive response. Whenever there was a
positive or negative response, the next weaker or stron-
ger filament was applied, respectively. This procedure
was done until six stimuli after the first change in
response had been observed. The 50% PWT was calcu-
lated using the following formula:
50%PWT = 10
(X+kδ)
f /104,w h e r eX f is the value of the
final von Frey filament used (in log units), k is a value
measured from the pattern of positive/negative
responses, and δ = 0.224, which is the average interval
(in log units) between the von Frey filaments [66]. If an
animal responded to the lowest von Frey filament, a
v a l u eo f0 . 2 5gw a sa s s i g n e d .I fa na n i m a ld i dn o t
respond to the highest von Frey filament, the value was
recorded as 15.0 g. Testing sessions were performed on
the day before injection and day 3, 7, 10, 14, 21 and 28
after tumor cells or sham injection. The mechanical
allodynia was assessed by measuring 50% PWT of ipsi-
lateral hind paw in tumor cells inoculated and sham-
operated rats, respectively. In rats, mechanical allodynia
is assessed by measuring 50% paw withdrawal threshold
(PWT) to von Frey filaments, and an allodynic rat is
defined as that the 50% PWT is less than 4.0 g, i.e. with-
drawal in response to non-noxious tactile stimulus [17].
Assessment of thermal hyperalgesia
Thermal hyperalgesia of the hind paws was tested as
described by our previous report [63]. Rats were allowed
to acclimate for a minimum of 30 min within acrylic
enclosures on a clear glass plate maintained at 30°C. A
radiant heat source was focused onto the plantar surface
of the hind paw. Measurements of paw withdrawal
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the activation of the heat source and stopped when
withdrawal of the paw was detected with a photodetec-
tor. A maximal cut-off time of 30 s was used to prevent
unnecessary tissue damage. Three measurements of
PWL were taken for each hind paw and were averaged
as the result of each test session. The hind paw was
tested alternately with greater than 5 min intervals
between consecutive tests.
Approximately 90% of rats implanted with tumor cells
exhibited sufficient mechanical allodynia and thermal
hyperalgesia, and were used in the electrophysiological
studies. Electrophysiological studies of DRG neurons in
tumor-bearing rats were performed 10 - 28 days after
implantation as mechanical allodynia and thermal
hyperalgesia are maximal during this period (Figure 1).
Measurement of TTX effects on pain behaviors in bone
cancer rats
Implantation of intrathecal catheter
Under chloral hydrate (0.3 g/kg, i.p.) anesthesia, implan-
tation of intrathecal cannula was performed as described
in our previous report [63]. Briefly, a PE-10 polyethylene
catheter was implanted between the L5 and L6 vertebrae
to reach the lumber enlargement of the spinal cord. The
outer part of the catheter was plugged and fixed onto
the skin on closure of the wound. All surgical proce-
dures were performed under sterile conditions. Rats
showing neurological deficits after the catheter implan-
tation were euthanized. Drugs or vehicle were intrathe-
cally injected via the implanted catheter in a 20-μl
volume of solution followed by 10 μlo fn o r m a ls a l i n e
(NS) for flushing. Each injection lasted at least 5 min.
After an injection, the needle remained in situ for 2 min
before being withdrawn.
Measurement of TTX effects
The 50% PWT to von Frey filaments and the PWL to
radiant heat were first measured as baseline control
before inoculation of tumor cells to rats. Implantation
of intrathecal catheter was performed on day 7 after
tumor cells inoculation. After assessing the rats’ motor
function by inclined-plate testing, intrathecal (i.t.) injec-
tion of tetrodotoxin (TTX) was performed once a day
on day 10 post-inoculation. The administration of TTX
lasted for 3 days to day 12 post-inoculation. The 50%
PWT to von Frey filaments, the PWL to radiant heat
and the inclined-plate test were then measured on day
12, 13, and 14 after tumor cells inoculation. TTX at the
dose of 10 μg/kg (in a 20-μl volume of solution), or nor-
mal saline in an equal volume, was intrathecally admini-
strated to the rat once a day.
Assessment of motor function
Inclined-plate test was used for the assessment of motor
function. The rat was placed crosswise to the long axis
of an inclined plate. The initial angle of the inclined
plate was 50 degrees. The angle was then adjusted in 5-
degree increments. The maximum angle of the plate on
which the rat maintained its body position for 5 s with-
out falling was determined according to the method
reported by Rivlin and Tator [67].
Whole-cell patch-clamp recording
Neurons were isolated from ipsilateral L4 and L5 DRG
of adult rats using methods as previously described [68].
Briefly, freshly dissected ganglia were minced and
washed in cold, oxygenated DMEM (Sigma, St. Louis,
MO), and were then subjected to collagenase (3 mg/ml,
type IA, Sigma) treatment for 45 min, followed by tryp-
sin (2 mg/ml, Type II-S, Sigma) for 15 min at 37°C. The
enzymatic reaction was stopped by washing the cells
with DMEM containing 10% fetal bovine serum (FBS),
and the remaining pieces of ganglia were gently tritu-
rated by using a fire-polished glass Pasteur pipette and
passed through a 40 μm cell strainer. The suspension
was then centrifuged at 800 rpm for 3 min, and the cell
pellet was resuspended in fresh DMEM supplemented
with 10% FBS. The dissociated cells were placed on
poly-D-lysine (0.1 mg/ml, sigma)-treated glass coverslips
contained within 24-well sterile tissue culture plates and
kept in 5% CO2 incubator at 37°C for 2-3 h before
recording.
Whole-cell current-clamp recordings were performed
at room temperature using an EPC-10 amplifier and
Patchmaster software (HEKA, Germany). Patch pipettes
were pulled from borosilicate glass capillaries with a tip
resistance of 2 - 5 MΩ when filled with internal solution
containing (in mM) 80 K-acetate, 30 KCl, 40 HEPES, 3
MgCl2,3E G T A ,a n d1C a C l 2, adjusted to pH 7.4 with
KOH. The external solution contained (in mM) 144
NaCl, 2.5 KCl, 2 CaCl2,0 . 5M g C l 2, 5 HEPES, and 10
Glucose, adjusted to pH 7.4 with NaOH. Action poten-
tials (AP) were measured with pipette and membrane
capacitance cancellation, filtered at 2 kHz and digitized
at 10 kHz. Series resistance was compensated 70 - 90%.
The membrane capacitance (Cm) was read from the
amplifier by software Patchmaster for determining the
size of cells.
For current-clamp recording, the cells were held at 0
pA, and the firing threshold of DRG neurons was first
measured by a series of 100-ms depolarizing current
injection in 5 pA steps from 0 pA to elicit the 1
st action
potential. To further examine the neurons firing proper-
ties, a large depolarizing current injection in 1 s, 300 pA
was delivered to elicit the cell generating sufficient fir-
ing. In our present study, a depolaring current pulse (1-
s, 300 pA) was injected in all neurons, because we tried
to ensure that the evoked discharges were elicited under
a equal depolaring current pulse in all neurons, so the
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brane properties were comparable between control and
experimental DRG neurons. We have demontrated that
this depolaring current pulse (1-s, 300 pA) could evoke
action potentials firing in all recorded small DRG neu-
rons in our preliminary experiments. A hyperpolarizing
current injection in 200 ms, -200 pA was used to mea-
sure membrane input resistance (Rin), which was
assessed from the value of the evoked membrane poten-
tial divided by the injected hyperpolarizing current (-200
pA). The following values were measured in this study
(Additional file 2: Figure S2): resting membrane poten-
tial (RMP), the depolarized current threshold for elicit-
ing the 1
st action potential (CT), threshold potential
(TP), rise rate of TP ((RMP-TP)/duration from RMP to
TP), amplitude of action potential (AP), overshot of AP;
duration of AP, amplitude of afterhyperpolarization
(AHP), AHP duration at 80% repolarization (AHP80%),
and frequency of AP.
Immunofluorescent staining of IB4, CGRP and TRPV1 in
isolated DRG neurons
IB4 staining of isolated DRG neurons
We used IB4-FITC (isolectin B4 conjugated to fluores-
cein isothiocyanate), which binds to living cells, to dis-
tinguish small-sized sensory neurons (soma diameter ≤
26 μm) capable of binding this lectin from other small
neurons. Briefly, the isolated DRG neurons were incu-
bated with IB4-FITC (10 μg/ml, Sigma-Aldrich) for 10
min and rinsed for 2 min, and the IB4-FITC staining
was then visualized. A neuron was considered IB4 posi-
tive if it had a continuous green ring around the peri-
meter [39].
Immunofluorescent staining of CGRP and TRPV1
For immunofluorescent staining of CGRP and TRPV1 in
isolated DRG neurons, the cells were rinsed in 0.1 M
phosphate-buffered saline (PBS, pH 7.4) two times, fixed
in 4% paraformaldehyde (in 0.1 M PB, pH 7.4) for 15
min, and soaked in 0.25% Triton X-100 (in 0.1 M PB,
pH 7.4) for 10 min. After blocking in 5% bovine serum
albumin (BSA) for 1 h, the cells were incubated with the
following primary antibodies as mouse anti-rat calcito-
nin gene-related peptide (CGRP, 1:1,000, Sigma) or rab-
bit anti-rat TRPV1 (1:1000, Santa Cruz Biotechnology)
in 1% BSA and 0.3% Triton-X100 (in 0.01 M PBS), over
night at 4°C. Control cells were processed without the
addition of primary antibody. After three rinses with
PBS, cells were incubated with secondary antibodies for
1 h at room temperature and washed three times with
PBS, in which the Alexa Fluor 488 goat anti-mouse IgG
(H + L) was used for CGRP staining and the Alexa fluor
568 goat anti-rabbit IgG (H + L) was used for TRPV1
staining. Both of them were purchased from Invitrogen
and were used at the dilution of 1:1000. Stained cells
were viewed and photographed with a CCD camera
under a fluorescent microscope (DMIRB, Leica,
Germany).
Single-cell reverse-transcriptase PCR
Single-cell reverse-transcriptase PCR was performed
according to the method as previously described [69]. In
brief, after current-clamp recording and measurement of
the neuron’s current threshold (CT), cytoplasm and
nucleus of the single recorded cell were harvested into
the patch pipette under visual control. The contents of
the patch pipette were expelled into a reaction tube con-
taining 2 μl prepared Random primer dilution (0.1 μg/μl,
Random primer 1 μl, DEPC·H2O1μl) and were incu-
bated at 70°C for 5 min. Reverse transcription of mRNA
transcripts were initiated by the addition of 18 μlp r e -
pared reverse transcription mixture containing: Moloney
murine leukemia virus (M-MLV) reverse transcriptase
RNase H (-) point mutant (Invitrogen) 0.5 μl (100 U), 5 ×
M-MLV buffer 4 μl, 10 mM dNTP 0.2 μl, and RNase
inhibitor (Rasin) 0.4 μl, adjusted to the final volume (18
μl) with DEPC·H2O, followed by incubation at 37°C for
45 min and 70°C for 10 min. A multiplex PCR protocol
was then used to amplify cDNA for TRPV1, CGRP and
actin simultaneously. Primers were designed as follows:
rat TRPV1, forward GACATGCCACCCA GCAGG and
reverse TCAATTCCCACACACCTCCC; rat CGRP, for-
ward AACCTTAGAA AGCAGCCCAGGCATG and
reverse GTGGGCACAAAGTTGTCCTTCACCA; rat
actin, forward AGCCATGTACGTAGCCATCC and
reverse GCCATCTCTTGCTCGAAGTC. Multiplex PCR
amplification was performed in a 20-μl reactive system
containing: a 10 μM concentration of each primer (for-
ward, reverse) 0.2 μl, reverse transcription (RT) product
2 μl, dNTP mix (10 mM each) 0.2 μl, Taq polymerase 0.2
μl (2 U), 10 × PCR buffer (Takara) 10 μl, adjusted to the
final volume (20 μl) with ddH2O. PCR amplification con-
sisted of 30 cycles of denaturation at 94°C for 30 s,
annealing at 57°C for 30 s, and elongation at 72°C for 30
s; followed by elongation at 72°C for 10 min. Two micro-
liter of the first-round PCR was reamplified in a second
PCR according to the same program. No signals were
detected in the absence of template. PCR products were
separated by electrophoresis on a 2% agarose gel contain-
ing 1 mg/ml ethidium bromide and visualized in a UV
transilluminator (Bio-Rad).
Statistical analysis
Statistical analyses were performed with GraphPad
Prism 5 for Windows (GraphPad Software, Inc, USA).
All data were expressed as mean ± S.E.M. Two-tailed
unpaired Student’s t-test was used for the comparison
of the mean values between two groups. One-way analy-
sis of variance (ANOVA) followed by Dunnett’s multiple
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ferroni post-hoc test was used for multiple comparison.
Differences with p < 0.05 were considered statistically
significant.
Additional material
Additional file 1: Figure S1. Comparasion of intrinsic membrane
properties of small-sized DRG neurons in MRMT-1-rats with or without
allodynia and hyperalgesia. (A): Resting membrane potentials (RMP) and
action potential threshold (TP). Representative of action potentials
evoked by 100-ms, 25-pA depolarizing current pulse, recorded from low-
firing threshold DRG neurons. RMP and TP are showed with arrow in the
figure. (B): Representative of the AHP amplitude and duration of action
potentials evoked by 100-ms, 40-pA depolarizing current pulse, recorded
from low-firing threshold DRG neurons. The vertical dot line to trough
shows the AHP amplitude, and the horizontal dot line shows the
AHP80%. Note that action potentials have been amputated due to high
gain. (C): Representative of the firing frequency evoked by a 1-s, 300-pA
depolarizing current pulse, recorded from low-firing threshold DRG
neurons. (a) in naive rat; (b) in MRMT-1-rat without allodynia; (c) in
MRMT-1-rat with allodynia.
Additional file 3: Table S1. Intrinsic electrogenic properties of small-
sized DRG neurons in MRMT-1-rats with or without allodynia. Values are
presented as mean ± S.E.M with the number given in parentheses. *p <
0.05, **p < 0.01,***p < 0.001, as compared with no allodynia groups, two-
tailed Student’s t-test. RMP: resting membrane potential; Rin: membrane
input resistance; CT: the depolarized current threshold for evoking the 1
st
action potential; TP: threshold potential; AHP: afterhyperpolarization;
AHP80% duration: AHP duration at 80% repolarization (AHP80%); AP: action
potential.
Additional file 4: Table S2. Summary of TRPV1 and CGRP mRNA
expression in LT (CT < 50 pA), MT (CT 50 ~ 100 pA), and HT (CT > 50
pA) DRG neurons using single-cell reverse-transcriptase PCR.
Additional file 2: Figure S2. Measured values for an action potential
recorded from small-sized DRG neurons. (A): amplitude of action
potential; (B): overshot of action potential; (C): duration of action
potential; (D): amplitude of afterhyperpolarization (AHP); (E): AHP duration
at 80% repolarization (AHP80%); (F): duration from resting membrane
potential (RMP) to threshold potential (TP); the rise rate of TP = (RMP-
TP)/duration from RMP to TP.
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